HERCULES · EFC16645
Public neurological clinical research study information. Check the current recruitment status in the live Wix study record.
A phase 3, randomized, double-blind study evaluating the efficacy and safety of SAR442168 versus placebo in patients with nonrelapsing secondary progressive multiple sclerosis (HERCULES). EudraCT: 2020-000647-30.
Sponsor: SANOFI
Phase: III
Area: Neuroimmunology